Cargando…

Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus

Type 2 diabetes mellitus is a major health problem worldwide with a steadily increasing prevalence reaching epidemic proportions. The major concern is the increased morbidity and mortality due to diabetic complications. Traditional but also nontraditional risk factors have been proposed to explain t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peppa, Melpomeni, Manta, Aspasia, Mavroeidi, Ioanna, Asimakopoulou, Athina, Syrigos, Alexandros, Nastos, Constantinos, Pikoulis, Emmanouil, Kollias, Anastasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675228/ https://www.ncbi.nlm.nih.gov/pubmed/38004506 http://dx.doi.org/10.3390/pharmaceutics15112526

Ejemplares similares

Dietary Approach of Patients with Hormone-Related Cancer Based on the Glycemic Index and Glycemic Load Estimates
por: Peppa, Melpomeni, et al.
Publicado: (2023)

Glycemic Index and Glycemic Load Estimates in the Dietary Approach of Polycystic Ovary Syndrome
por: Manta, Aspasia, et al.
Publicado: (2023)

Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease
por: Peppa, Melpomeni, et al.
Publicado: (2021)

Synchronous Sternal Metastasectomy and Total Thyroidectomy for Differentiated Thyroid Cancer: A Rare Case Report
por: Paspala, Anna, et al.
Publicado: (2022)

Colorectal Surgery in the COVID-19 Era: A Systematic Review and Meta-Analysis
por: Pararas, Nikolaos, et al.
Publicado: (2022)

Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus
por: Suzuki, Yuta, et al.
Publicado: (2022)

A Rare Case of a Metastatic Lung Squamous Cell Carcinoma to the Large Bowel and the Liver
por: Pararas, Nikolaos, et al.
Publicado: (2021)

Secondary diabetes mellitus in acromegaly
por: Moustaki, Melpomeni, et al.
Publicado: (2023)

SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
por: Tentolouris, Anastasios, et al.
Publicado: (2019)

Precision Surgery of Colorectal Liver Metastases in the Current Era: A Systematic Review
por: Papaconstantinou, Dimitrios, et al.
Publicado: (2023)

“Starting from the Image”: A Tele-pathology Pre-graduate Course Aimed at Motivating Medical Students
por: Lazari, Evgenia-Charikleia, et al.
Publicado: (2023)

The effect of the COVID pandemic lockdown measures on surgical emergencies: experience and lessons learned from a Greek tertiary hospital
por: Pikoulis, Emmanouil, et al.
Publicado: (2021)

Oncologic outcomes of patients with resectable primary gastric squamous cell carcinoma: a systematic review
por: Schizas, Dimitrios, et al.
Publicado: (2022)

Secondary diabetes mellitus in pheochromocytomas and paragangliomas
por: Moustaki, Melpomeni, et al.
Publicado: (2023)

Primary non-Hodgkin lymphoma of the extra-hepatic bile duct: A case report
por: Pararas, Nikolaos, et al.
Publicado: (2022)

The Protective Effect of Bariatric Surgery on the Development of Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Pararas, Nikolaos, et al.
Publicado: (2023)

Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis
por: Drexel, Heinz, et al.
Publicado: (2019)

Experiential student study groups: perspectives on medical education in the post-COVID-19 period
por: Lazari, Evgenia Charikleia, et al.
Publicado: (2023)

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review
por: Rabizadeh, Soghra, et al.
Publicado: (2019)

Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors
por: Vargas-Delgado, Ariana P., et al.
Publicado: (2023)

A modern web-based health promotion program for patients in Greece with diabetes 2 and obesity: an interventional study
por: Chrysi, Maria S., et al.
Publicado: (2023)

Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis
por: Li, Xuefeng, et al.
Publicado: (2022)

Association between SGLT2 Inhibitors and Cardiac Rehabilitation Outcomes in Patients with Cardiovascular Disease and Type 2 Diabetes Mellitus
por: Kashima, Ayuko, et al.
Publicado: (2022)

The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
por: Tilinca, Mariana Cornelia, et al.
Publicado: (2021)

Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers
por: Gessner, Arne, et al.
Publicado: (2022)

Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors
por: Frąk, Weronika, et al.
Publicado: (2023)

Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
por: Ghezzi, Chiara, et al.
Publicado: (2018)

Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes
por: Chipayo-Gonzales, David, et al.
Publicado: (2023)

Editorial to the IJMS Special Issue on Sglt2 Inhibitors Vol. 1
por: Lymperopoulos, Anastasios
Publicado: (2023)

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?
por: Kollias, Anastasios, et al.
Publicado: (2021)

Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy
por: Nashawi, Mouhamed, et al.
Publicado: (2021)

Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
por: Kaushal, Shaveta, et al.
Publicado: (2014)

Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
por: Lymperopoulos, Anastasios, et al.
Publicado: (2021)

The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
por: Pitt, Bertram, et al.
Publicado: (2021)

Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
por: Peppa, Melpomeni, et al.
Publicado: (2011)

Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
por: El Hage, Lea, et al.
Publicado: (2020)

Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases?
por: Nomiyama, Takashi
Publicado: (2020)

Cardiac injury and prognosis in COVID-19: Methodological considerations and updated meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2020)

Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
por: Kollias, Anastasios, et al.
Publicado: (2021)

Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk
por: Giorgino, Francesco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p60ohtg42i5rn5bj4r0s0d20a1